- Home
- MDXG vs XPRO Comparison
MDXG vs XPRO Comparison
Compare MDXG & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- XPRO
- Stock Information
- Founded
- MDXG 2006
- XPRO 1938
- Country
- MDXG United States
- XPRO United States
- Employees
- MDXG N/A
- XPRO N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- XPRO Oilfield Services/Equipment
- Sector
- MDXG Health Care
- XPRO Energy
- Exchange
- MDXG Nasdaq
- XPRO Nasdaq
- Market Cap
- MDXG 1.2B
- XPRO 1.2B
- IPO Year
- MDXG N/A
- XPRO 2013
- Fundamental
- Price
- MDXG $7.50
- XPRO $9.92
- Analyst Decision
- MDXG Strong Buy
- XPRO Buy
- Analyst Count
- MDXG 3
- XPRO 3
- Target Price
- MDXG $12.00
- XPRO $22.00
- AVG Volume (30 Days)
- MDXG 527.3K
- XPRO 1.4M
- Earning Date
- MDXG 04-29-2025
- XPRO 04-24-2025
- Dividend Yield
- MDXG N/A
- XPRO N/A
- EPS Growth
- MDXG N/A
- XPRO N/A
- EPS
- MDXG 0.28
- XPRO 0.45
- Revenue
- MDXG $348,879,000.00
- XPRO $1,712,802,000.00
- Revenue This Year
- MDXG $10.09
- XPRO $3.75
- Revenue Next Year
- MDXG $11.77
- XPRO $3.26
- P/E Ratio
- MDXG $27.14
- XPRO $22.09
- Revenue Growth
- MDXG 8.52
- XPRO 13.22
- 52 Week Low
- MDXG $5.47
- XPRO $9.66
- 52 Week High
- MDXG $10.14
- XPRO $24.50
- Technical
- Relative Strength Index (RSI)
- MDXG 36.84
- XPRO 34.41
- Support Level
- MDXG $7.41
- XPRO $10.24
- Resistance Level
- MDXG $8.12
- XPRO $10.96
- Average True Range (ATR)
- MDXG 0.23
- XPRO 0.41
- MACD
- MDXG -0.03
- XPRO 0.02
- Stochastic Oscillator
- MDXG 12.50
- XPRO 16.67
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.